Frontiers in Immunology | Vaccines and Molecular Therapeutics

Original Research

Published on 14 Oct 2024

Pulmonary SARS-CoV-2 infection leads to para-infectious immune activation in the brain

in Vaccines and Molecular Therapeutics

Cordelia Dunai
Claire Hetherington
Sarah A. Boardman
Jordan J. Clark
Parul Sharma
Krishanthi Subramaniam
Kukatharmini Tharmaratnam
Edward J. Needham
Robyn Williams
Yun Huang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1440324

2,333 views

Review

Published on 11 Oct 2024

Advancements in monkeypox vaccines development: a critical review of emerging technologies

in Vaccines and Molecular Therapeutics

Igor Garcia-Atutxa
Paul Mondragon-Teran
Alejandro Huerta-Saquero
Francisca Villanueva-Flores

Frontiers in Immunology

doi 10.3389/fimmu.2024.1456060

4,594 views
1 citation

Original Research

Published on 10 Oct 2024

High prevalence of long COVID in anti-TPO positive euthyroid individuals with strongly elevated SARS-CoV-2-specific T cell responses and moderately raised anti-spike IgG levels 23 months post-infection

in Vaccines and Molecular Therapeutics

Zsolt Matula
Viktória Király
Gabriella Bekő
Márton Gönczi
András Zóka
Róbert Steinhauser
Ferenc Uher
István Vályi-Nagy

Frontiers in Immunology

doi 10.3389/fimmu.2024.1448659

1,699 views

Original Research

Published on 08 Oct 2024

The self-assembled nanoparticle-based multi-epitope influenza mRNA vaccine elicits protective immunity against H1N1 and B influenza viruses in mice

in Vaccines and Molecular Therapeutics

Yaxin Di
Chenchao Zhang
Zilin Ren
Renyue Jiang
Jiafeng Tang
Songhui Yang
Ziliang Wang
Tong Yu
Tong Zhang
Ziping Yu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1483720

2,432 views

Brief Research Report

Published on 07 Oct 2024

Analysis of B-cell receptor repertoire to evaluate the immunogenicity of SARS-CoV-2 RBD mRNA vaccine: MAFB-7256a (DS-5670d)

in Vaccines and Molecular Therapeutics

Goh Ohji
Yohei Funakoshi
Kimikazu Yakushijin
Takaji Matsutani
Tomoki Sasaki
Takahiro Kusakabe
Sakuya Matsumoto
Taiji Koyama
Yoshiaki Nagatani
Keiji Kurata

Frontiers in Immunology

doi 10.3389/fimmu.2024.1468760

1,563 views

Systematic Review

Published on 03 Oct 2024

DNA and RNA vaccines against tuberculosis: a scoping review of human and animal studies

in Vaccines and Molecular Therapeutics

Alisa Kazakova
Pavel Zhelnov
Roman Sidorov
Anna Rogova
Olga Vasileva
Roman Ivanov
Vasiliy Reshetnikov
Albert Muslimov

Frontiers in Immunology

doi 10.3389/fimmu.2024.1457327

2,509 views
4 citations

Review

Published on 03 Oct 2024

Towards personalized vaccines

in Vaccines and Molecular Therapeutics

Davide Montin
Veronica Santilli
Alessandra Beni
Giorgio Costagliola
Baldassarre Martire
Maria Felicia Mastrototaro
Giorgio Ottaviano
Caterina Rizzo
Mayla Sgrulletti
Michele Miraglia Del Giudice

Frontiers in Immunology

doi 10.3389/fimmu.2024.1436108

1,706 views

Original Research

Published on 02 Oct 2024

M protein ectodomain-specific immunity restrains SARS-CoV-2 variants replication

in Vaccines and Molecular Therapeutics

Yibo Tang
Kaiming Tang
Yunqi Hu
Zi-Wei Ye
Wanyu Luo
Cuiting Luo
Hehe Cao
Ran Wang
Xinyu Yue
Dejian Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1450114

2,151 views

Correction

Published on 02 Oct 2024

Corrigendum: MAVS disruption impairs downstream signaling and results in higher virus replication levels of salmonid alphavirus subtype 3 but not infectious pancreatic necrosis virus in vitro

in Vaccines and Molecular Therapeutics

Cheng Xu
Amr A. A. Gamil
Xiaolin Wang
Hetron Mweemba Munang’andu
Øystein Evensen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1500204

1,456 views

Original Research

Published on 01 Oct 2024

Nanospheres as the delivery vehicle: novel application of Toxoplasma gondii ribosomal protein S2 in PLGA and chitosan nanospheres against acute toxoplasmosis

in Vaccines and Molecular Therapeutics

WeiYu Qi
YouLi Yu
ChenChen Yang
XiaoJuan Wang
YuChen Jiang
Li Zhang
ZhengQing Yu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1475280

2,900 views

Review

Published on 01 Oct 2024

Future applications of host direct therapies for infectious disease treatment

in Vaccines and Molecular Therapeutics

Ruth E. Thom
R V. D’Elia

Frontiers in Immunology

doi 10.3389/fimmu.2024.1436557

1,847 views
2 citations

Original Research

Published on 01 Oct 2024

Prognostic significance of fludeoxyglucose positron emission tomography delta radiomics following bridging therapy in patients with large B-cell lymphoma undergoing CAR T-cell therapy

in Vaccines and Molecular Therapeutics

Colton Ladbury
Claire Hao
William Tyler Watkins
Sagus Sampath
Jeffrey Wong
Arya Amini
Karen Sokolov
Jekwon Yeh
Karine A. Al Feghali
Dorine de Jong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1419788

1,117 views
1 citation

Review

Published on 30 Sep 2024

Integrating machine learning to advance epitope mapping

in Vaccines and Molecular Therapeutics

Simranjit Grewal
Nidhi Hegde
Stephanie K. Yanow

Frontiers in Immunology

doi 10.3389/fimmu.2024.1463931

2,326 views

Correction

Published on 25 Sep 2024

Corrigendum: Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV

in Vaccines and Molecular Therapeutics

Shi Zou
Wei Guo
Songjie Wu
Fangzhao Ming
Yuting Tan
Mengmeng Wu
Weiming Tang
Ke Liang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1494940

521 views

Original Research

Published on 24 Sep 2024

Signal peptide exchange alters HIV-1 envelope antigenicity and immunogenicity

in Vaccines and Molecular Therapeutics

Chitra Upadhyay
Priyanka Rao
Mohammad Amin Behzadi
Roya Feyznezhad
Gregory S. Lambert
Rajnish Kumar
Madhu Kumar
Weiming Yang
Xunqing Jiang
Christina C. Luo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1476924

1,337 views
1 citation

Original Research

Published on 24 Sep 2024

Characterisation and Immunogenicity of Neisseria cinerea outer membrane vesicles displaying NadA, NHBA and fHbp from Neisseria meningitidis serogroup B

in Vaccines and Molecular Therapeutics

Shathviga Manoharan
Theo A. Farman
Stavroula Piliou
Pietro Mastroeni

Frontiers in Immunology

doi 10.3389/fimmu.2024.1473064

1,466 views

Navigation group

Articles

Pulmonary SARS-CoV-2 infection leads to para-infectious immune activation in the brain

Advancements in monkeypox vaccines development: a critical review of emerging technologies

High prevalence of long COVID in anti-TPO positive euthyroid individuals with strongly elevated SARS-CoV-2-specific T cell responses and moderately raised anti-spike IgG levels 23 months post-infection

The self-assembled nanoparticle-based multi-epitope influenza mRNA vaccine elicits protective immunity against H1N1 and B influenza viruses in mice

Analysis of B-cell receptor repertoire to evaluate the immunogenicity of SARS-CoV-2 RBD mRNA vaccine: MAFB-7256a (DS-5670d)

DNA and RNA vaccines against tuberculosis: a scoping review of human and animal studies

Towards personalized vaccines

M protein ectodomain-specific immunity restrains SARS-CoV-2 variants replication

Corrigendum: MAVS disruption impairs downstream signaling and results in higher virus replication levels of salmonid alphavirus subtype 3 but not infectious pancreatic necrosis virus in vitro

Nanospheres as the delivery vehicle: novel application of Toxoplasma gondii ribosomal protein S2 in PLGA and chitosan nanospheres against acute toxoplasmosis

Future applications of host direct therapies for infectious disease treatment

Prognostic significance of fludeoxyglucose positron emission tomography delta radiomics following bridging therapy in patients with large B-cell lymphoma undergoing CAR T-cell therapy

Integrating machine learning to advance epitope mapping

Corrigendum: Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV

Signal peptide exchange alters HIV-1 envelope antigenicity and immunogenicity

Characterisation and Immunogenicity of Neisseria cinerea outer membrane vesicles displaying NadA, NHBA and fHbp from Neisseria meningitidis serogroup B